SANUWAVE Health (SNWV) Stock Price, News & Analysis

Company Overview

SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's pulsed acoustic cellular expression systems, including dermaPACE system for treating diabetic foot ulcers and other chronic wounds; orthoPACE system for treating tendinopathies and acute and nonunion fractures; and Profile is used to provide solution for pain management in sports medicine and physical therapy. Its portfolio of wound treatment solutions provides patients with a noninvasive technology that boosts the body's normal healing and tissue regeneration processes. In addition, the company offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds. SANUWAVE Health, Inc. was founded in 2004 and is headquartered in Eden Prairie, Minnesota.

Key Stats

• Today's Range: $35.90 to $36.94
• 50-Day Range: $24.72 to $38.71
• 52-Week Range: $4.28 to $39.50
• Volume: 18,224 shs
• Average Volume: 17,336 shs
• Market Capitalization: $312.47 million
• P/E Ratio: 4.39
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SANUWAVE Health Stock Analysis - MarketRank™

SANUWAVE Health scored higher than 31% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for SANUWAVE Health.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of SANUWAVE Health is 4.39, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 22.46.

Price to Earnings Ratio vs. Sector

The P/E ratio of SANUWAVE Health is 4.39, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 23.68.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.65% of the float of SANUWAVE Health has been sold short.

Short Interest Ratio / Days to Cover

SANUWAVE Health has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in SANUWAVE Health has recently decreased by 18.18%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

SANUWAVE Health does not currently pay a dividend.

Dividend Growth

SANUWAVE Health does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.65% of the float of SANUWAVE Health has been sold short.

Short Interest Ratio / Days to Cover

SANUWAVE Health has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in SANUWAVE Health has recently decreased by 18.18%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: 0.00

News Coverage This Week

MarketBeat has tracked 2 news articles for SANUWAVE Health this week, compared to 0 articles on an average week.

MarketBeat Follows

1 people have added SANUWAVE Health to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, SANUWAVE Health insiders have not sold or bought any company stock.

Percentage Held by Insiders

36.60% of the stock of SANUWAVE Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

42.53% of the stock of SANUWAVE Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

SNWV Stock Analysis - Frequently Asked Questions

How have SNWV shares performed this year?

SANUWAVE Health's stock was trading at $23.00 at the beginning of 2025. Since then, SNWV stock has increased by 58.9% and is now trading at $36.55.
View the best growth stocks for 2025 here.

How were SANUWAVE Health's earnings last quarter?

SANUWAVE Health, Inc. (OTCMKTS:SNWV) announced its quarterly earnings data on Monday, November, 16th. The company reported ($7.50) earnings per share (EPS) for the quarter, missing the consensus estimate of ($3.75) by $3.75. The business earned $1.97 million during the quarter. SANUWAVE Health had a negative trailing twelve-month return on equity of 23.83% and a negative net margin of 1.33%.

When did SANUWAVE Health's stock split?

SANUWAVE Health shares reverse split on Friday, October 18th 2024. The 1-375 reverse split was announced on Wednesday, October 16th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 17th 2024. An investor that had 100 shares of stock prior to the reverse split would have 0 shares after the split.

How do I buy shares of SANUWAVE Health?

Shares of SNWV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of SANUWAVE Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that SANUWAVE Health investors own include Co-Diagnostics (CODX), iBio (IBIO), Onconova Therapeutics (ONTX), Tonix Pharmaceuticals (TNXP), T2 Biosystems (TTOO), Kopin (KOPN) and VBI Vaccines (VBIV).

Company Calendar

• Last Earnings: 11/16/2020
• Today: 3/31/2025
• Next Earnings (Estimated): 5/08/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:SNWV
• CIK: 1417663
• Web: www.sanuwave.com
• Phone: (770) 419-7525
• Fax: 770-419-8634
• Employees: 40
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($3.90)
• Trailing P/E Ratio: 4.39
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-25,810,000.00
• Net Margins: -1.33%
• Pretax Margin: -1.31%
• Return on Equity: -23.83%
• Return on Assets: -20.60%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.12
• Quick Ratio: 0.08

Sales & Book Value

• Annual Sales: $32.63 million
• Price / Sales: 9.57
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($14.02) per share
• Price / Book: -2.61

Miscellaneous

• Outstanding Shares: 8,549,000
• Free Float: 5,418,000
• Market Cap: $312.47 million
• Optionable: Not Optionable
• Beta: 1.54